MedPath

Somnial Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Early Feasibility Study of Transcutaneous Upper Airway Stimulation in Obstructive Sleep Apnea

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
OSA
Interventions
Device: Transcutaneous Upper Airway Stimulation Device
First Posted Date
2023-05-31
Last Posted Date
2023-05-31
Lead Sponsor
Somnial Inc
Target Recruit Count
12
Registration Number
NCT05881512
Locations
🇺🇸

United Diagnostics, Commack, New York, United States

© Copyright 2025. All Rights Reserved by MedPath